(Q43246091)
Statements
1 reference
A phase II trial of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active EGFR mutations: Okayama Lung Cancer Study Group trial 0705. (English)
1 reference
Mitsune Tanimoto
1 reference
Katsuyuki Kiura
1 reference
Katsuyuki Hotta
1 reference
Shingo Harita
1 reference
Akihiro Bessho
1 reference
Nagio Takigawa
1 reference
Yoshihiko Segawa
1 reference
Haruhito Kamei
1 reference
Hiroshige Yoshioka
1 reference
Shigeki Umemura
1 reference
Shoichi Kuyama
1 reference
Okayama Lung Cancer Study Group
1 reference
Hidetoshi Hayashi
1 reference
Masahiro Tabata
1 reference
1 January 2010
1 reference
1 reference
5
1 reference
1
1 reference
99-104
1 reference
Identifiers
1 reference
1 reference